메뉴 건너뛰기




Volumn 12, Issue 3, 2009, Pages 165-168

Novel therapeutic strategies in prostate cancer: Establishing a stratification system for patient selection in targeted trials

Author keywords

Clinical trial; Molecular target; Personalized therapy; Prostate cancer

Indexed keywords

ABIRATERONE; BEVACIZUMAB; BEZ 235; BICALUTAMIDE; CARBON 11; DOCETAXEL; ERLOTINIB; EVEROLIMUS; GEFITINIB; MAMMALIAN TARGET OF RAPAMYCIN; MDV 3100; MOLECULAR MARKER; PANOBINOSTAT; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PREDNISONE; TANESPIMYCIN; TESTOSTERONE; TETRAHYDROLIPSTATIN; TRASTUZUMAB; UNCLASSIFIED DRUG; VORINOSTAT; XL 765;

EID: 62249192007     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (3)

References (4)
  • 1
    • 46349084468 scopus 로고    scopus 로고
    • Multiple oncogenic pathway signatures show coordinate expression patterns in human prostate tumors
    • Creighton CJ: Multiple oncogenic pathway signatures show coordinate expression patterns in human prostate tumors. PLoS ONE (2008) 3(3):e1816.
    • (2008) PLoS ONE , vol.3 , Issue.3
    • Creighton, C.J.1
  • 3
    • 9244222261 scopus 로고    scopus 로고
    • Targeted cancer therapy
    • Sawyers C: Targeted cancer therapy. Nature (2004) 432 (7015):294-297.
    • (2004) Nature , vol.432 , Issue.7015 , pp. 294-297
    • Sawyers, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.